Immunodeficiency in MS

Status unconfirmed

Conditions studied: Multiple Sclerosis, Hypogammaglobulinemia, Immunodeficiency, Infection, Bacterial

In brief

The purpose of this study is to identify if there is a relationship between multiple sclerosis disease-modifying therapy exposure, immunodeficiencies, and infection risk in subjects living with MS.

Key facts

Study ID

NCT04447937

Run by

Advanced Neurosciences Institute

People needed

1500

Starts

2020-06-29

Expected to finish

2021-07-30

Last updated by the study team

2020-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• One or more immunoglobulin level results and medical history available
• 18 years of age or older at the time of data collection
• Patients with first symptom MS or other isolated demyelinating syndromes, neuromyelitis optica, or rheumatic-associated CNS inflammation

You may not qualify if…

• No evidence of CNS autoimmune disease
• Less than 18 years of age at the time of data abstraction
• Undergoing plasma exchange at the time of any lab tests drawn

Where it is running

• Advanced Neurosciences Institute — Franklin, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.